Follow
James M Wright
James M Wright
Professor Emeritus of Anesthesiology, Pharmacology & Therapeutics, University of BC
Verified email at ubc.ca - Homepage
Title
Cited by
Cited by
Year
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled …
R Boussageon, T Bejan-Angoulvant, M Saadatian-Elahi, S Lafont, ...
Bmj 343, 2011
10712011
First‐line drugs for hypertension
JM Wright, VM Musini, R Gill
Cochrane Database of systematic reviews, 2018
7442018
Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children
RL Morrow, EJ Garland, JM Wright, M Maclure, S Taylor, CR Dormuth
Cmaj 184 (7), 755-762, 2012
3492012
Pharmacotherapy for mild hypertension
D Diao, JM Wright, DK Cundiff, F Gueyffier
The Cochrane Library, 2012
3462012
Treatment blood pressure targets for hypertension
JA Arguedas, MI Perez, JM Wright
Cochrane database of systematic reviews, 2009
3312009
Pharmacotherapy for hypertension in the elderly
VM Musini, AM Tejani, K Bassett, JM Wright
Cochrane Database of Systematic Reviews, 2009
3072009
Should people at low risk of cardiovascular disease take a statin?
JD Abramson, HG Rosenberg, N Jewell, JM Wright
Bmj 347, 2013
3002013
Statin adherence and risk of accidents: a cautionary tale
CR Dormuth, AR Patrick, WH Shrank, JM Wright, RJ Glynn, J Sutherland, ...
Circulation 119 (15), 2051-2057, 2009
2832009
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin
RJ Ferguson, SMF De Morais, S Benhamou, C Bouchardy, J Blaisdell, ...
Journal of Pharmacology and Experimental Therapeutics 284 (1), 356-361, 1998
2801998
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials
T Bejan-Angoulvant, M Saadatian-Elahi, JM Wright, EB Schron, ...
Journal of hypertension 28 (7), 1366-1372, 2010
2552010
Blood pressure‐lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
VM Musini, M Nazer, K Bassett, JM Wright
Cochrane Database of Systematic Reviews, 2014
2442014
Lipid lowering efficacy of atorvastatin
SP Adams, M Tsang, JM Wright
Cochrane database of systematic reviews, 2012
242*2012
Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
ECK Li, BS Heran, JM Wright
Cochrane Database of Systematic Reviews, 2014
2382014
Blood pressure targets for hypertension in people with diabetes mellitus
JA Arguedas, V Leiva, JM Wright
Cochrane Database of Systematic Reviews, 2013
2332013
The double-edged sword of COX-2 selective NSAIDs
JM Wright
CMAJ 167 (10), 1131-1137, 2002
2332002
Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?
JM Wright, CH Lee, GK Chambers
CMAJ 161 (1), 25-32, 1999
2231999
Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension
BS Heran, MMY Wong, IK Heran, JM Wright
Cochrane Database of Systematic Reviews, 2008
2212008
Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by four different antioxidants in the mouse
TL Perry, VW Yong, RM Clavier, K Jones, JM Wright, JG Foulks, RA Wall
Neuroscience letters 60 (2), 109-114, 1985
2201985
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib
JB Hrachovec, M Mora, JM Wright, TL Perry, K Bassett, K Chambers
JAMA 286 (19), 2398-2400, 2001
2112001
Are lipid-lowering guidelines evidence-based?
J Abramson, JM Wright
The Lancet 369 (9557), 168-169, 2007
2102007
The system can't perform the operation now. Try again later.
Articles 1–20